COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
BetaGlue Therapeutics is a Milan-based clinical-stage company developing YntraDose/BAT-90 personalized loco-regional radiotherapy platforms for unresectable solid tumors, advancing multiple clinical programs across oncology indications.
